0001415889-15-003713.txt : 20151113
0001415889-15-003713.hdr.sgml : 20151113
20151113174542
ACCESSION NUMBER: 0001415889-15-003713
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20151111
FILED AS OF DATE: 20151113
DATE AS OF CHANGE: 20151113
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACADIA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001070494
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 061376651
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3611 VALLEY CENTRE DRIVE
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 858-558-2871
MAIL ADDRESS:
STREET 1: 3611 VALLEY CENTRE DRIVE
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Iversen Leslie L
CENTRAL INDEX KEY: 0001291623
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50768
FILM NUMBER: 151230453
MAIL ADDRESS:
STREET 1: C/O UNIVERSITY OF OXFORD
STREET 2: MANSFIELD ROAD
CITY: OXFORD
STATE: X0
ZIP: OX1 3QT
4
1
form4-11132015_021134.xml
X0306
4
2015-11-11
0001070494
ACADIA PHARMACEUTICALS INC
ACAD
0001291623
Iversen Leslie L
3611 VALLEY CENTRE DRIVE, SUITE 300
SAN DIEGO
CA
92130
true
false
false
false
Common Stock
2015-11-11
4
M
0
6000
9.04
A
42127
D
Common Stock
2015-11-11
4
M
0
10000
9.04
A
52127
D
Common Stock
2015-11-11
4
M
0
9126
9.04
A
61253
D
Common Stock
2015-11-11
4
M
0
4874
1.75
A
66127
D
Common Stock
2015-11-11
4
S
0
30000
36.0109
D
36127
D
Stock option (right to buy)
9.04
2015-11-11
4
M
0
6000
0
D
2016-06-12
Common Stock
6000
0
D
Stock option (right to buy)
9.04
2015-11-11
4
M
0
10000
0
D
2016-06-12
Common Stock
10000
0
D
Stock option (right to buy)
9.04
2015-11-11
4
M
0
9126
0
D
2016-06-12
Common Stock
9126
0
D
Stock option (right to buy)
1.75
2015-11-11
4
M
0
4874
0
D
2021-06-09
Common Stock
4874
33697
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in September 2015.
The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $35.67 to $36.44 per share, inclusive. The reporting person undertakes to provide ACADIA Pharmaceuticals Inc., any security holder of ACADIA Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the foregoing range.
25% of the shares subject to the Stock Option vested and became exercisable at the end of each 3-month period following the grant date of June 13, 2006.
25% of the shares subject to the Stock Option vested and became exercisable at the end of each 3-month period following the grant date of June 10, 2011.
/s/ Glenn F. Baity, Attorney-in-Fact
2015-11-13